Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the unaudited Standalone ....
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics has informed BSE that its Board of Directors will meet on Wednesday, November 12, 2025, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025 (Q2FY26 / H1FY26). The trading window for insiders remains closed until November 14, 2025, though it remains open for general investors. The filing is a standard compliance intimation under SEBI LODR Regulations.
The announcement itself is a routine regulatory notice with no financial data disclosed — actual results and any impact on the stock will only be known after the board meeting on November 12. Investors should watch for the results announcement and any management commentary.